Norgine is a European specialty pharmaceutical company, founded in 1906 and based in Amsterdam, best known in cancer care for bowel preparations used before colonoscopy and for in-licensed cancer medicines.
Norgine is a privately held European pharmaceutical company headquartered in Amsterdam with a history going back to 1906. It markets gastroenterology and supportive-care products, including bowel-cleansing preparations used ahead of colonoscopy and colorectal cancer screening, and licenses oncology medicines for Europe and Australia. It appears on ClinicalTrials.gov as lead sponsor of phase 3 trials in cancer settings.
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Pivotal (registrational) trial, Clinical trial, Colorectal cancer.
Shares Pivotal (registrational) trial, Clinical trial, Colorectal cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/